Steve Duffy

Digital Content Editor

Most Recent Articles by Steve Duffy

FDA Panel Votes in Favor of Abuse-Deterrent Oxycodone Reformulation

By Nov 15, 2018

The vote was taken in a joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee.

FDA Proposes New Restrictions on Sale of Electronic Nicotine Delivery Systems

By Nov 15, 2018

The announcement comes in the wake of results from the 2018 National Youth Tobacco Survey which showed a 78% increase in current e-cigarette use among high school students from 2017 to 2018.

Lasmiditan NDA Submitted for Acute Treatment of Migraine

By Nov 14, 2018

The NDA submission included data from two Phase 3 trials, SAMURAI and SPARTAN.

Glecaprevir/Pibrentasvir 8-Week Regimen Evaluated in Treatment-Naïve HCV Patients With Compensated Cirrhosis

By Nov 14, 2018

In EXPEDITION-8, 280 treatment-naïve HCV patients (genotypes 1, 2, 4, 5, and 6) with compensated cirrhosis were treated with Mavyret for 8-weeks; the primary efficacy measure was SVR12 rate.

FDA Fast-Tracks Treatment for Pachyonychia Congenita

By Nov 13, 2018

Through Palvella's proprietary QTORIN formulation, PTX-022 targets basal keratinocytes, which harbor the mutant keratin genes that cause PC.

More Articles by Steve Duffy